Endonovo Therapeutics, Inc. ENDV
0.00 USD 0.00 (+0.00%)
At closeNov 9, 2026, 4:00 PM EST
0.0001 Day range 0.0001
0.00005 52-week range 0.00014
- YTD
- 0.00%
- 1 year
- 0.00%
- Market cap
- 180.75K
- EPS (ttm)
- 0.29
- P/E ratio
- 0.00
- YTD return
- 0.00%
- 1-year return
- 0.00%
- Volume
- 409.41K
- Avg volume
- 344.59K
- Open
- 0.0001
- Previous close
- 0.0001
- Day's range
- 0.0001 – 0.0001
- 52-week range
- 0.00005 – 0.00014
- Earnings date
- Feb 11, 2025
5D 0.0000 (0.00%)
No chart data for this range yet.
Next earnings
Feb 11, 2025
Expected Feb 11, 2025. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 11, 2025 | Dec 1, 2024 | 0.00 | — | — | — |
| Nov 12, 2024 | Sep 1, 2024 | 0.00 | 0.00 | — | — |
| Aug 22, 2024 | Jun 1, 2024 | 0.00 | 0.00 | — | — |
| Jul 1, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Dec 28, 2023 | Sep 1, 2023 | 0.00 | 0.00 | — | — |
News
Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc 
Endonovo's SofPulse® to Be Featured at Innovative Pain Management Solutions 
Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc. for a minimum of $50 Million 
Endonovo's SofPulse® Secures Taiwan FDA Approval 
Endonovo's SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution 
Endonovo's Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Update 
Stocks That Hit 52-Week Lows On Tuesday 
Stocks That Hit 52-Week Lows On Friday 
Stocks That Hit 52-Week Lows On Thursday - Stocks That Hit 52-Week Lows On Tuesday
Your note
Sign in to keep a note on ENDV — it syncs with the Stock Master app.